Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies.

ABSTRACT:

SUBMITTER: Bogenberger JM 

PROVIDER: S-EPMC4331188 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature